Cochlear downgraded to Hold

When we upgraded Cochlear to Buy in Cochlear: Interim result 2014 12 Feb 14 (Buy – $54.64) we noted – in the context of our $55 Buy price – that 'whether you pay $54 or $56 isn't going to matter in the long run'. But it will make a difference paying over $58. As a result, with the stock up 8% since 12 Feb, we're downgrading back to HOLD. Note: Our model Growth Portfolio owns shares in Cochlear.

When we upgraded Cochlear to Buy in Cochlear: Interim result 2014 12 Feb 14 (Buy – $54.64) we noted – in the context of our $55 Buy price – that 'whether you pay $54 or $56 isn't going to matter in the long run'. But it will make a difference paying over $58. As a result, with the stock up 8% since 12 Feb, we're downgrading back to HOLD.

Note: Our model Growth Portfolio owns shares in Cochlear.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles